Relative Contraindications Active or recent malignancy Pregnancy or breastfeeding (no safety data) Active systemic infection Uncontrolled autoimmune disease in acute flare Concurrent use of anticoagulants without physician oversight Regulatory Status and Where to Source BPC-157 FDA Status (as of 2025) BPC-157 is not FDA-approved for any human therapeutic indication
The ergonomic design is meant to be convenient and help the user maintain consistency in administration procedures according to the manufacturers guidelines
Requires low-temperature storage to maintain structural stability
Allergic reactions , whilst rare, can occur and range from mild skin reactions to severe anaphylaxis
BPC-157 is part of a growing list of compounds called peptides gaining interest in fitness, wellness, and antiaging circles
Since peptides usually arent well-absorbed in the digestive system, their effects are often limited when taken orally, It is important to note that the same may apply to BPC-157 and it may only have local effects on the stomach when taken orally